Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
783.40
-9.50 (-1.20%)
At close: Feb 10, 2026

Ambee Pharmaceuticals Income Statement

Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
193.9230.55219.3198.1180.9998.98
Revenue Growth (YoY)
-16.50%5.13%10.71%9.45%82.86%-65.31%
Cost of Revenue
102.17119.16103.1492.5383.6258.27
Gross Profit
91.72111.39116.16105.5697.3740.71
Selling, General & Admin
84.94104103.7592.3982.5147.99
Operating Expenses
84.94104103.7592.3982.5147.99
Operating Income
6.787.3912.4113.1714.86-7.28
Interest Expense
-0.07-0.09-0.58-2.49-4.62-5
Other Non Operating Income (Expenses)
-0-0-0-0
EBT Excluding Unusual Items
6.717.311.8310.6810.23-12.28
Pretax Income
6.717.311.8310.6810.23-12.28
Income Tax Expense
1.891.992.151.592.180.73
Net Income
4.825.319.689.098.06-13.01
Net Income to Common
4.825.319.689.098.06-13.01
Net Income Growth
-51.41%-45.17%6.53%12.79%--
Shares Outstanding (Basic)
222222
Shares Outstanding (Diluted)
222222
EPS (Basic)
2.012.214.033.793.36-5.42
EPS (Diluted)
2.012.214.033.793.36-5.42
EPS Growth
-51.41%-45.17%6.53%12.79%--
Free Cash Flow
-8.9-2.06-68.12-35.34-74.71-5.45
Free Cash Flow Per Share
-3.71-0.86-28.39-14.72-31.13-2.27
Dividend Per Share
1.0001.0001.0001.5001.000-
Dividend Growth
---33.33%50.00%--
Gross Margin
47.30%48.31%52.97%53.29%53.80%41.13%
Operating Margin
3.50%3.21%5.66%6.65%8.21%-7.36%
Profit Margin
2.49%2.30%4.42%4.59%4.45%-13.14%
Free Cash Flow Margin
-4.59%-0.89%-31.06%-17.84%-41.28%-5.51%
EBITDA
-12.4618.2620.1619.64-1.67
EBITDA Margin
-5.40%8.32%10.18%10.85%-1.69%
D&A For EBITDA
-5.075.846.994.795.61
EBIT
6.787.3912.4113.1714.86-7.28
EBIT Margin
3.50%3.20%5.66%6.65%8.21%-7.36%
Effective Tax Rate
28.21%27.26%18.16%14.90%21.25%-
Advertising Expenses
-0.821.121.434.580.93
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.